
Noble E. Jarrell
Examiner (ID: 14167, Phone: (571)272-9077 , Office: P/1625 )
| Most Active Art Unit | 1699 |
| Art Unit(s) | 1625, 1699, 1622, 1624, 1609 |
| Total Applications | 1419 |
| Issued Applications | 950 |
| Pending Applications | 180 |
| Abandoned Applications | 334 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15227467
[patent_doc_number] => 10501443
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-10
[patent_title] => Pyridone compound as c-met inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/343387
[patent_app_country] => US
[patent_app_date] => 2017-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11126
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 204
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343387
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/343387 | Pyridone compound as c-met inhibitor | Oct 26, 2017 | Issued |
Array
(
[id] => 14836129
[patent_doc_number] => 20190276465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => Nitrogen-Containing Heterocyclic Compounds As FXR Modulators
[patent_app_type] => utility
[patent_app_number] => 16/346807
[patent_app_country] => US
[patent_app_date] => 2017-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 345
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16346807
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/346807 | Nitrogen-containing heterocyclic compounds as FXR modulators | Oct 26, 2017 | Issued |
Array
(
[id] => 15556669
[patent_doc_number] => 20200062746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => PROCESS FOR THE PREPARATION OF (3S,4S)-TETRAHYDROFURAN-3-YL 4-ISOPROPYL-6,7-DIHYDRO-3H-IMIDAZO[4,5-C]PYRIDINE-5(4H)-CARBOXYLATE
[patent_app_type] => utility
[patent_app_number] => 16/344608
[patent_app_country] => US
[patent_app_date] => 2017-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4212
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16344608
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/344608 | Process for the preparation of (3S,4S)-tetrahydrofuran-3-yl 4-isopropyl-6,7-dihydro-3H-imidazo[4,5-C]pyridine-5(4H)-carboxylate | Oct 24, 2017 | Issued |
Array
(
[id] => 14682177
[patent_doc_number] => 20190240203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => NOVEL ANTIBIOTICS AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/342903
[patent_app_country] => US
[patent_app_date] => 2017-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22878
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16342903
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/342903 | Antibiotics and methods of using same | Oct 19, 2017 | Issued |
Array
(
[id] => 16665055
[patent_doc_number] => 10934286
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => Heterocyclic sulfones as ROR gamma modulators
[patent_app_type] => utility
[patent_app_number] => 16/341474
[patent_app_country] => US
[patent_app_date] => 2017-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27671
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 225
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341474
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/341474 | Heterocyclic sulfones as ROR gamma modulators | Oct 11, 2017 | Issued |
Array
(
[id] => 14864621
[patent_doc_number] => 20190282552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => Treatment of synucleinopathies
[patent_app_type] => utility
[patent_app_number] => 16/340929
[patent_app_country] => US
[patent_app_date] => 2017-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16340929
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/340929 | Treatment of synucleinopathies | Oct 9, 2017 | Issued |
Array
(
[id] => 14993517
[patent_doc_number] => 20190315716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => HETEROARYL COMPOUNDS AND THEIR USE AS MER INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/341005
[patent_app_country] => US
[patent_app_date] => 2017-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63030
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 749
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341005
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/341005 | Heteroaryl compounds and their use as Mer inhibitors | Oct 8, 2017 | Issued |
Array
(
[id] => 16832101
[patent_doc_number] => 11008342
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-18
[patent_title] => Crystalline polymorphs of a muscarinic acetylcholine receptor agonist
[patent_app_type] => utility
[patent_app_number] => 16/338930
[patent_app_country] => US
[patent_app_date] => 2017-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 25
[patent_no_of_words] => 23127
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16338930
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/338930 | Crystalline polymorphs of a muscarinic acetylcholine receptor agonist | Oct 4, 2017 | Issued |
Array
(
[id] => 14624505
[patent_doc_number] => 20190225620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => IMIDAZOPYRIDAZINE COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES
[patent_app_type] => utility
[patent_app_number] => 16/339744
[patent_app_country] => US
[patent_app_date] => 2017-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16339744
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/339744 | Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or INF alpha responses | Oct 1, 2017 | Issued |
Array
(
[id] => 15163213
[patent_doc_number] => 10487086
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-26
[patent_title] => Macrocycles as factor XIa inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/718431
[patent_app_country] => US
[patent_app_date] => 2017-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 96214
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15718431
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/718431 | Macrocycles as factor XIa inhibitors | Sep 27, 2017 | Issued |
Array
(
[id] => 16360972
[patent_doc_number] => 20200317723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => Bioconjugation of Polypeptides
[patent_app_type] => utility
[patent_app_number] => 16/650357
[patent_app_country] => US
[patent_app_date] => 2017-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16650357
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/650357 | Bioconjugation of polypeptides | Sep 26, 2017 | Issued |
Array
(
[id] => 12124997
[patent_doc_number] => 20180008583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'METHOD FOR MANUFACTURING NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF AND MANUFACTURING INTERMEDIATE OF NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/712815
[patent_app_country] => US
[patent_app_date] => 2017-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 29886
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15712815
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/712815 | METHOD FOR MANUFACTURING NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF AND MANUFACTURING INTERMEDIATE OF NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF | Sep 21, 2017 | Abandoned |
Array
(
[id] => 15666393
[patent_doc_number] => 10597414
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-24
[patent_title] => Crystalline polymorphic form of 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-OXO-2l5-[1,2]oxaphosphinane
[patent_app_type] => utility
[patent_app_number] => 16/332983
[patent_app_country] => US
[patent_app_date] => 2017-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 7297
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16332983
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/332983 | Crystalline polymorphic form of 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-OXO-2l5-[1,2]oxaphosphinane | Sep 18, 2017 | Issued |
Array
(
[id] => 12241206
[patent_doc_number] => 20180074068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'FLUORESCENT PROBES FOR DETECTING HYDROGEN POLYSULFIDES'
[patent_app_type] => utility
[patent_app_number] => 15/704101
[patent_app_country] => US
[patent_app_date] => 2017-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8727
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15704101
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/704101 | Fluorescent probes for detecting hydrogen polysulfides | Sep 13, 2017 | Issued |
Array
(
[id] => 12118752
[patent_doc_number] => 20180002338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS'
[patent_app_type] => utility
[patent_app_number] => 15/703945
[patent_app_country] => US
[patent_app_date] => 2017-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 65
[patent_figures_cnt] => 65
[patent_no_of_words] => 20092
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15703945
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/703945 | Short-acting benzodiazepine salts and their polymorphic forms | Sep 12, 2017 | Issued |
Array
(
[id] => 16028071
[patent_doc_number] => 10676442
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-09
[patent_title] => Salt derivative of tetrahydroisoquinoline and crystalline thereof and preparation method therefore and application thereof
[patent_app_type] => utility
[patent_app_number] => 16/329685
[patent_app_country] => US
[patent_app_date] => 2017-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 37
[patent_no_of_words] => 5996
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16329685
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/329685 | Salt derivative of tetrahydroisoquinoline and crystalline thereof and preparation method therefore and application thereof | Aug 29, 2017 | Issued |
Array
(
[id] => 12239921
[patent_doc_number] => 20180072784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'TFPI INHIBITORS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/681074
[patent_app_country] => US
[patent_app_date] => 2017-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 179
[patent_figures_cnt] => 179
[patent_no_of_words] => 27771
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15681074
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/681074 | TFPI inhibitors and methods of use | Aug 17, 2017 | Issued |
Array
(
[id] => 14746695
[patent_doc_number] => 20190256521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => NORTHERN-SOUTHERN ROUTE TO SYNTHESIS OF BACTERIOCHLORINS
[patent_app_type] => utility
[patent_app_number] => 16/323607
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16323607
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/323607 | Northern-southern route to synthesis of bacteriochlorins | Aug 16, 2017 | Issued |
Array
(
[id] => 16590509
[patent_doc_number] => 10899759
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-26
[patent_title] => Positive allosteric modulators of the muscarinic acetylcholine receptor M1
[patent_app_type] => utility
[patent_app_number] => 16/337977
[patent_app_country] => US
[patent_app_date] => 2017-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21707
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16337977
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/337977 | Positive allosteric modulators of the muscarinic acetylcholine receptor M1 | Aug 15, 2017 | Issued |
Array
(
[id] => 16586435
[patent_doc_number] => 20210020837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => SPIROACRIDINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/320273
[patent_app_country] => US
[patent_app_date] => 2017-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320273
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320273 | Spiroacridine derivatives | Aug 10, 2017 | Issued |